جست‌وجوی استاد و پژوهشگر

• Natural Products Research
• Phytomedicine
• Herbal Product Standardization
• +۷ مورد دیگر

Roles & Affiliations: Ikhlas Khan serves as Director of the National Center for Natural Products Research (NCNPR), Distinguished Professor, and Research Professor of Pharmacognosy at the University of Mississippi's School of Pharmacy. He also leads the FDA Program and coordinates natural products research across multiple initiatives, including the Sino-US TCM Research Center and the Center for Research of Indian Systems of Medicine (CRISM). Education: B.Sc. Chemistry (1980) - Aligarh Muslim University, India M.Sc. Organic Chemistry (1982) - Aligarh Muslim University, India Ph.D. Pharmacy (1987) - Ludwig-Maximilians-Universität, Munich Postdoctoral Studies - Swiss Federal Institute of Technology (ETH), Zurich Research Focus: Dr. Khan specializes in natural products research with emphasis on: Phytomedicine: Standardization of herbal products via analytical fingerprinting, pesticide/herbicide residue analysis, and bioanalytical quality control. Drug Discovery: Isolation of bioactive natural products, development of analytical methods for phytochemical characterization, and chiral separation techniques. Metabolism Studies: Role of metabolism in drug/natural product activity, particularly in aminoquinoline antimalarials. His work bridges academia, industry, and regulatory bodies, shaping policies for botanical supplements. Key Contributions: Over 850 peer-reviewed publications and leadership in high-impact projects like the FDA Center of Excellence. His lab pioneered methods to combat herbal product adulteration and safety issues. Awards & Recognition: UM Distinguished Professor Award (2018) Wiley Award (AOAC International, 2018) Qihuang International Prize (2017) Honoris Causa Doctorate (University of Hamdard, 2012) Labs & Collaborations: Directs the NCNPR, a global leader in natural products research, and collaborates with institutions worldwide. His team develops technologies for herbal product authentication and drug metabolism studies.

• Cellular Toxicology
• In Vitro Methodology
• Fish Cell Biology
• +۲ مورد دیگر

Dr. Vivian Dayeh is an Associate Professor in the Department of Biology at the University of Waterloo, where she joined in 2004 as a full-time lecturer. Her roles include Teaching Fellow, Undergrad Advisor for Biomedical Science and Medical Physiology, and coordinator of the Biotech Technician Diploma program. Ph.D. Biology, University of Waterloo (2004) M.Sc. Biology, University of Waterloo (2001) B.Sc. Biology, University of Waterloo (1999) Dr. Dayeh specializes in cellular toxicology and in vitro methodology development , focusing on alternatives to whole-organism testing in aquatic environments. Her work explores toxicant effects on fish cells, particularly gill and intestinal epithelial systems, and employs protozoa as toxicity indicators. Recent research examines temperature and nutritional stress impacts on cell viability. Her publications from 2004-2025 demonstrate expertise in fish cell culture , cytotoxicity assays , and environmental contaminant testing , with applications in regulatory toxicology and industrial effluent analysis. 2024 Service Award, Society for In Vitro Biology 2021 Fellow Award, Society for In Vitro Biology Multiple Outstanding Performance Awards (2006-2020) Jack Carlson Teaching Excellence Awards (2006, 2018) Joseph F. Morgan Awards (2002, 2003) As an educator, Dr. Dayeh teaches core courses including Introductory Cell Biology , Human Anatomy , Human Physiology , Environmental Toxicology , and Animal Cell Biotechnology . She serves on the SIVB Board and facilitates instructional skills workshops.

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۱۲ مورد دیگر

Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.

John A. Copland, IIIمشاهده پروفایل

استاد

• Cancer Biology
• Molecular Carcinogenesis
• Translational Research
• +۳ مورد دیگر

Dr. John A. Copland III is a Professor of Cancer Biology and Biochemistry & Molecular Biology at Mayo Clinic in Jacksonville, Florida. He leads the Cancer Biology and Translational Research Laboratory, focusing on molecular mechanisms of carcinogenesis, tumor progression, and development of targeted cancer therapies. Education: PhD in Physiology & Endocrinology (Medical College of Georgia), MS in Endocrinology (Medical College of Georgia), BS in Chemistry (Columbus College), with postdoctoral training at University of Texas Medical Branch. Research interests center on: Identifying tumor suppressor genes (e.g., RhoB, TBR3, GATA3) and oncogenes (e.g., FOXO3a, SCD1, NPTX2). Developing patient-derived xenografts and live cell models for personalized medicine. Designing SCD1 inhibitors via in silico modeling for clinical trials. Recent publications highlight his work on SCD1 inhibition in leukemia and thyroid cancer ImmunoPET imaging of thyroid tumors CRISPR-identified drug synergies in cholangiocarcinoma Patient-specific combination therapies using xenograft models

Joseph P. Bresslerمشاهده پروفایل

دانشیار

• Neurotoxicology
• Environmental Health Sciences
• Metal Transporters
• +۱۲ مورد دیگر

Joseph P. Bressler is an Associate Professor at Johns Hopkins University, jointly affiliated with the Bloomberg School of Public Health and the Krieger School of Arts and Sciences. He is a member of the Department of Environmental Health and Engineering and conducts research at the Kennedy Krieger Institute in Baltimore, Maryland. His work bridges public health, neuroscience, and molecular toxicology, focusing on environmental impacts on brain development. Education: PhD, Rutgers University, 1978 Dr. Bressler’s research centers on neurotoxicology, particularly how environmental pollutants such as lead, cadmium, and aluminum disrupt metal transport systems and affect neurodevelopment. His laboratory investigates the role of iron and other metal transporters at the blood-brain barrier and in glial cells, revealing mechanisms of metal uptake and toxicity. His work has implications for understanding autism, fetal alcohol syndrome, and other neurodevelopmental disorders. His recent publications highlight ongoing research into metal homeostasis, cytotoxicity in cancer and neuronal cell lines, e-cigarette aerosol variability, and epigenetic changes in sex chromosome aneuploidies. The research spans molecular mechanisms, in vitro models, and human health outcomes, demonstrating a multidisciplinary approach to environmental health. Scientific Contributions: Elucidated how lead and cadmium hijack iron transporters to enter the brain Demonstrated aluminum activation of iron uptake pathways in glial cells Investigated flavoring agents like ethyl maltol in enhancing metal toxicity Explored epigenetic and behavioral impacts in rare genetic conditions Dr. Bressler has advised numerous researchers and collaborators across disciplines. His work has been supported by federal and institutional grants, though specific funding details are not provided in the source text. He actively publishes in high-impact toxicology and environmental health journals, with research cited in policy and public health discussions. He leads a research laboratory focused on cellular and molecular mechanisms of neurotoxicity, utilizing in vitro models of the blood-brain barrier, astrocytes, and neuronal cell lines. His team collaborates widely across neuroscience, public health, and environmental engineering domains.

Anja Boisenمشاهده پروفایل

استاد

• Drug Delivery
• Sensing Technologies
• Nanotechnology
• +۳ مورد دیگر

Anja Boisen is a Professor and Head of the Drug Delivery and Sensing Section at the Department of Health Technology, Technical University of Denmark (DTU). Her research focuses on advanced drug delivery systems, sensing technologies, and nanotechnology applications in biomedical engineering. She leads a multidisciplinary team developing innovative devices such as microcontainers, microneedles, and lab-on-a-disc platforms for targeted drug delivery and diagnostics. Her work contributes to UN Sustainable Development Goals, particularly in improving health and reducing inequalities. Key research areas include surface-enhanced Raman spectroscopy (SERS), microfabrication for medical devices, and biomaterials for tissue engineering. She has supervised multiple PhD students, including projects on oral drug delivery systems, gastrointestinal retention devices, and energy-harvesting materials for biomedical applications. Boisen’s team has pioneered technologies like self-unfolding foils for oral delivery and smart drug delivery microparticles. Their innovations aim to enhance therapeutic efficacy while minimizing side effects. She has been recognized with the Sensor Division Outstanding Achievement Award (2022) for her contributions to sensor technology. Her lab actively collaborates internationally, advancing applications in cancer therapy, antibiotic monitoring, and gut microbiota research. Current projects explore high-throughput 3D tumor modeling, SERS-based diagnostics, and biodegradable materials for bone fixation.

• Nanomedicine
• Drug Delivery Systems
• Cellular Uptake of Nanoparticles
• +۳ مورد دیگر

Anna Salvati is an Associate Professor specializing in nanomedicine and drug delivery systems. Her research focuses on nanoparticle-cell interactions, biomolecular corona formation, and the physicochemical properties governing nanomaterial behavior in biological environments. Key research themes include cellular uptake mechanisms, toxicity of nanomaterials, and nanoparticle targeting strategies. Recent publications highlight her work on nanoparticle stability, membrane interactions, and environmental impacts of microplastics. Her studies integrate multiomics approaches, advanced imaging, and interlaboratory validation to address challenges in nanomedicine design and safety testing. Current projects explore the role of high-density lipoproteins in nanoparticle functionality and the modulation of drug release kinetics through material engineering.

Jessica Rosenholmمشاهده پروفایل

استاد

• Drug Delivery Systems
• Nanomedicine
• Biomaterials Engineering
• +۶ مورد دیگر

Jessica Rosenholm is a Professor at the Faculty of Science and Engineering, Department of Pharmacy at Åbo Akademi University. Her research focuses on drug delivery systems, nanomedicine, and biomaterials engineering. She holds a D.Sc.(Tech.) and has authored over 200 publications. Key research areas include mesoporous silica nanoparticles, 3D bioprinting, and antimicrobial resistance solutions. Her work contributes to UN Sustainable Development Goals, particularly in advancing health technologies. Notable achievements include the Akzo Nobel Nordic Research Prize 2009 and the Knight, First Class, of the Order of the White Rose of Finland (2022). She leads projects like the MADNESS Centre of Excellence, exploring materials-driven solutions against antimicrobial resistance. Education: Doctor of Science (Technology) Research Interests: Nanoformulations, biomedical imaging, microfluidics, and tissue engineering. Recent articles highlight innovations in programmable nanocomposites for hearing loss treatment, microfluidic assembly of nanostructures, and 3D printing of drug delivery systems. Awards: ÅAU Chancellor’s Prize (2013), Forskarpriset ur Harry Elvings legat (2009) Grants: Projects funded by EU, Finnish Research Council, and Sigrid Jusélius Foundation. Labs/Teams: BioNanoMaterials group explores cutting-edge technologies like nanomedical agents and microfluidics. Current projects include the NAP4DIVE initiative for blood-brain barrier drug delivery.

Xian Wuمشاهده پروفایل

استادیار

• Developmental Toxicology
• Stem Cell Models
• Neurotoxicology
• +۵ مورد دیگر

Xian Wu, Ph.D., serves as a Research Assistant Professor in the Department of Pharmacology & Toxicology at East Carolina University's Brody School of Medicine. Her research leverages human stem cell models to investigate developmental vulnerabilities to environmental contaminants in cardiovascular and neural systems, with emphasis on epigenetic mechanisms and disease modeling. Dr. Wu's academic credentials include: Ph.D. in Toxicology from the University of Georgia M.S. in Biomedicine from East China Normal University B.S. in Biotechnology from Anhui University Her postdoctoral training comprised a Fellowship at the National Institute of Environmental Health Sciences and an ORISE Fellowship at the U.S. Food and Drug Administration. Research focuses on creating human stem cell-derived organoid systems to model developmental toxicology, particularly examining cardiac and neural development under chemical exposure. The laboratory employs fluorescence reporter systems and RNA-seq to identify critical vulnerability windows during early development, with recent work targeting Parkinson's disease mechanisms through dopaminergic neuron models and cardiac fibrosis via advanced organoids. Methodological innovations include high-content imaging for neurogenesis quantification and epigenetic pathway analysis. Publication trends (2016-2025) demonstrate consistent advancement in stem cell-based toxicology testing, with increasing emphasis on micro/nanoplastics risk assessment, arsenic neurotoxicity mechanisms, and doxorubicin cardiotoxicity modeling. The work bridges environmental health, epigenetics, and regenerative medicine through interdisciplinary approaches. Scientific recognition includes: 2025 SPARC Award (ECU) 2024 Top Abstract Award (Developmental Origins of Health and Disease Society) 2024 NIEHS P30 Center Travel Award 2023 ECU Research and Creative Activity Award Dr. Wu actively mentors graduate researchers including Ph.D. candidate Cate Duncan and M.S. students Kamilah Muhammad and Bailey Skeen, alongside undergraduate Bryce Tilghman. Former trainees McKyrah Brown and Monica Cross completed honors theses in the laboratory. Current grants include ECU's SPARC Award funding stem cell model development for environmental contaminant testing. The BSOM 6S-11 laboratory maintains specialized capabilities in cardiac and cerebral organoid generation, fluorescence-based toxicity screening, and RNA-seq epigenetic analysis. Collaborative networks include the National Institute of Environmental Health Sciences and ECU's Center for Human Health and the Environment, supporting translational research on developmental vulnerability periods.

Awadhesh N. Jhaمشاهده پروفایل

استاد

• Genetic Toxicology
• Ecotoxicology
• Marine Pollution
• +۱۲ مورد دیگر

Professor Awadhesh N. Jha is a Professor in Genetic Toxicology and Ecotoxicology at the School of Biological and Marine Sciences , University of Plymouth, UK. He has been a leading figure in environmental toxicology since joining the university in 1996, rising to full professorship in 2010. He leads the Environmental and Applied Biology Research Group and the Genetic Toxicology and Ecotoxicology Research Group, and served as REF UoA6 Coordinator (2014–2022). His educational background includes a PhD in Radiation Cytogenetics from Banaras Hindu University, India (1989), followed by post-doctoral work at Leiden University, Netherlands, and a role at ICI/Zeneca’s marine toxicology lab before transitioning to academia. Professor Jha’s research focuses on the genotoxic and ecotoxic impacts of environmental stressors such as radionuclides, engineered nanoparticles, PAHs, and emerging contaminants on aquatic organisms. He employs multidisciplinary and innovative methodologies, including in vitro models like fish cell spheroids (‘Virtual Fish’ project), to assess DNA damage, develop biomarkers, and reduce reliance on live animal testing. His work integrates molecular biology, chemistry, and environmental science to evaluate risks to marine ecosystems and human health. The recent research articles reflect a strong trend in marine pollution, radiation biology, and environmental risk assessment , with increasing emphasis on emerging issues like tritium release from nuclear facilities, AI-assisted landfill risk modeling, and sunscreen toxicity. His studies often involve international collaborations and real-world policy implications. Scientific Awards and Recognitions: Jim Parry Award, UKEMS (2021) Fellow of the Royal Society of Biology (FRSB, 2015) VC’s World Class Researcher Award Finalist (2010, 2012) Plymouth Pioneers Recognition UK Nominated Expert, UN WOA III (2023) Supervision and Grants: Professor Jha has supervised 26 PhD students to completion and mentored over 10 post-doctoral researchers. He has led major funded projects including TRANSAT (€5M, Horizon 2020), SPHERTOX , and TITANS , funded by EU, NERC, BBSRC, IAEA, and industry partners like AstraZeneca and Unilever. His work directly informs environmental policy and nuclear safety regulations. Laboratories and Teams: He leads the Genetic Toxicology and Ecotoxicology Research Group and is central to the Environmental and Applied Biology Research Group at Plymouth. His team collaborates internationally with institutions in France, Italy, Spain, Brazil, and India, and contributes to the South West Nuclear Hub. The lab specializes in advanced analytical methods, comet assays, and 3D cell culture models.

• Neurodegenerative Diseases
• Molecular Neuroscience
• Stem Cell Research
• +۳ مورد دیگر

Professor Richard Wade-Martins is a leading academic in University of Oxford 's Department of Physiology, Anatomy and Genetics . He directs the Molecular Neurodegeneration Research Laboratory and the Oxford Parkinson’s Disease Centre (OPDC). With degrees from Cambridge (MA) and Oxford (DPhil), he has held prestigious fellowships including Wellcome Trust Research Career Development Fellowship and NIH reviewer roles. His research targets molecular mechanisms in Parkinson’s and Alzheimer’s diseases through iPSC models , transgenic mice , and lysosomal function studies . He pioneered work on SNCA , MAPT , and LRRK2 gene pathways. Current projects focus on gene therapy and mitochondrial dysfunction in neurodegeneration. Key publications (2019–2025) reveal trends in single-cell transcriptomics , calcium channel inhibition , and TFEB/TFE3 lysosome modulation . His awards include Wellcome Trust Fellowships and advisory roles for Parkinson's UK , Alzheimer's Research UK , and EU consortia like StemBANCC and EFACTS . He leads the UK Dementia Platform iPSC Initiative and serves on international boards in Luxembourg and Canada.

Eric Morganمشاهده پروفایل

استاد

• Parasitology
• Epidemiology
• Climate Change Impact on Disease Dynamics
• +۶ مورد دیگر

Professor Eric Morgan at Queen's University Belfast leads parasitology research in the School of Biological Sciences , focusing on climate-driven epidemiology of parasitic infections in animals. His work integrates predictive modeling, parasite transmission dynamics at the wild-domestic interface, and sustainable livestock health solutions. Veterinary parasitology and climate change impact Anthelmintic resistance mitigation strategies AI-enhanced diagnostic systems for animal health Current research students include Anthony George, who investigates Combining alternative approaches for helminth control in grazing livestock . Public engagement initiatives like the BUG Consortium and Poo Patrol translate findings into practical parasite management. His recent publications in 2025 address topics like flood reactors, zoonotic toxocariasis, and precision agriculture tools for parasite risk assessment.

Nicholas M. Kanaanمشاهده پروفایل

استاد

• Neurodegenerative Diseases
• Alzheimer's Disease
• Parkinson's Disease
• +۶ مورد دیگر

Nicholas M. Kanaan is a Professor of Translational Neuroscience and holds the Maibach Smiley Professorship of Alzheimer's Research at Michigan State University's College of Human Medicine. He serves as Director of Advanced Microscopy and is faculty in both the MSU Neuroscience Program and the MSU BioMolecular Science Gateway. His research is centered at the Grand Rapids Research Center where he leads the Kanaan Laboratory. Dr. Kanaan received his B.S. in Neuroscience, Psychology, and Sociology from Central Michigan University in 2001, followed by a Ph.D. in Neurological Sciences from Rush University Medical Center in 2007. He completed postdoctoral training at Northwestern University from 2007-2010 under Dr. Lester Binder. His research focuses on neurodegenerative diseases, particularly Alzheimer's disease (AD) and Parkinson's disease (PD), with emphasis on tau protein pathology. The Kanaan Lab investigates mechanisms underlying degenerative diseases using a combination of in vitro and in vivo model systems. A major focus is understanding how disease-related alterations in tau cause neuronal dysfunction through disruption of axonal transport. His lab has identified a phosphatase-activating domain (PAD) in tau that inhibits anterograde fast axonal transport. Analysis of Dr. Kanaan's publication record reveals a consistent focus on tau protein biology, with recent work emphasizing iPSC models, CRISPR screening, tau proteostasis, and therapeutic interventions targeting tau phosphorylation and oligomerization. His research spans basic molecular mechanisms to translational applications, with increasing use of primate models and advanced screening technologies in recent years. Scientific Awards and Recognition: Maibach Smiley Alzheimer's Research Professor Maibach Smiley Professor of Alzheimer's Research Dr. Kanaan mentors numerous students and postdoctoral fellows in his laboratory, with research supported by multiple grants focused on understanding and treating neurodegenerative diseases. His lab employs a wide range of technical expertise including recombinant protein purification, cell culture, monoclonal antibody production, various microscopy techniques, and behavioral testing in rodent models. Outside the lab, Dr. Kanaan enjoys photography, woodworking, and fishing.

• Environmental Chemistry
• Ecotoxicology
• Exposure Assessment
• +۵ مورد دیگر

M.T.O. (Chiel) Jonker is an Assistant Professor at the Faculty of Veterinary Medicine , Utrecht University , affiliated with the Institute for Risk Assessment Sciences (IRAS) and its Toxicology division . He specializes in exposure assessment of hydrophobic organic chemicals (e.g., PFAS , PAHs , PCBs ), focusing on sorption processes , bioaccumulation dynamics , and passive sampling techniques in both in vivo and in vitro settings. His research emphasizes methodological innovation for high-quality chemical analysis (GC-MS, LC-MS) and environmental risk assessment . Recent work includes PFAS degradation , sediment toxicity testing , and temperature/salinity effects on contaminant partitioning. His 2018-2024 publications highlight passive sampling calibration , mechanistic toxicity models , and bioavailability prediction using polyoxymethylene and silicone rubber samplers .

Soeren Lienkampمشاهده پروفایل

استادیار

• Molecular Biology
• Genetics
• Developmental Biology
• +۵ مورد دیگر

Prof. Dr. Soeren Lienkamp is an Assistant Professor at the Institute of Anatomy , Faculty of Medicine , University of Zurich . His work bridges digital education and genetic research , focusing on enhancing medical teaching through innovative formats. Research Interests : Genetics, developmental biology, kidney disease modeling, CRISPR applications, digital medical education, and advanced microscopy. Methodologies : Combines Xenopus tropicalis models, deep learning , and bioengineering to study genetic kidney disorders and improve diagnostic tools. Publication Trends : His recent articles highlight predictable genome editing , 3D imaging technologies , and mechanistic insights into kidney and eye development. Earlier works focus on ciliary function , Wnt signaling , and metabolic stress in renal cells.